A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Summary
- Eligibility
- for people ages 12 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Wanxing Chai-Ho, MD

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Wanxing Chai-Ho, MD
HS Assistant Clinical Professor, Medicine. Authored (or co-authored) 15 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Incyte Corporation
- Links
- A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease Sign up for this study
- ID
- NCT06388564
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 120 study participants
- Last Updated